Macrocytic anemia and thrombocytosis associated with thymoma : A case reportGRUMBECK, E; AIGINGER, P; GISSLINGER, B et al.American journal of hematology. 2000, Vol 63, Num 1, pp 38-41, issn 0361-8609Article

Prognostic significance of serial determinations of lactate dehydrogenase (LDH) in the follow-up of patients with myelodysplastic syndromesWIMAZAL, F; SPERR, W. R; KUNDI, M et al.Annals of oncology. 2008, Vol 19, Num 5, pp 970-976, issn 0923-7534, 7 p.Article

Post-transplant acute myeloid leukemia (PT-AML)THALHAMMER-SCHERRER, R; WIESELTHALER, G; MUEHLBACHER, F et al.Leukemia. 1999, Vol 13, Num 3, pp 321-326, issn 0887-6924Article

Survival analysis and AML development in patients with de novo myelodysplastic syndromes: comparison of six different prognostic scoring systemsSPERR, W. R; WIMAZAL, F; VALENT, P et al.Annals of hematology (Print). 2001, Vol 80, Num 5, pp 272-277, issn 0939-5555Article

Multiple-dose pharmacokinetics of cefepime in long-term hemodialysis with high-flux membranesSCHMALDIENST, S; TRAUNMÜLLER, F; BURGMANN, H et al.European journal of clinical pharmacology. 2000, Vol 56, Num 1, pp 61-64, issn 0031-6970Article

Competitive CBFβ/MYH11 reverse-transcriptase polymerase chain reaction for quantitative assessment of minimal residual disease during postremission therapy in acute myeloid leukemia with inversion(16) : A pilot studyLACZIKA, K; NOVAK, M; SCHWARZINGER, I et al.Journal of clinical oncology. 1998, Vol 16, Num 4, pp 1519-1525, issn 0732-183XArticle